<DOC>
	<DOCNO>NCT02125799</DOCNO>
	<brief_summary>High frequency repetitive transcranial magnetic stimulation ( HF-rTMS ) show safety efficacy treatment-resistant depression , require daily treatment 4-6 week . Accelerated HF-TMS ( aHF-rTMS ) , treatment deliver less time , would significant advantage term access , patient acceptance cost . In present open label trial investigator intend assess effectiveness acceptability novel aHF-rTMS protocol ( i.e. , 2 daily session 2 consecutive week ; 6,000 pulse per day ) . For , depressed outpatient receive aHF-rTMS protocol assess baseline week 3 9 several clinician- patient- report measure well computerized neurocognitive test .</brief_summary>
	<brief_title>Accelerated rTMS Treatment-Resistant Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Presence current major depressive disorder ( accord DSMIVTR ) improve ≥ 2 adequate antidepressant trial ( ) current episode ; Baseline score ≥ 13 QIDSC Stable medication regimen ( &gt; = 4 week ) prior study enrolment Psychotic feature current episode Lifetime history psychotic disorder and/or bipolar I II disorder Substance alcohol abuse/dependence past 6 month Lifetime history major neurological disease ( e.g. , Parkinson 's , stroke ) Uncontrolled medical disease ( e.g. , cardiovascular , renal ) Pregnancy and/or lactation Presence specific contraindication rTMS ( e.g. , personal history epilepsy , metallic head implant ) Hearing loss</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>